Oltipraz treatment in experimental schistosomiasis mansoni: VII effect of high dose oral therapy on alkaline phosphatase level in livers of infected mice

ABSTRACT

Biochemical estimation of alkaline phosphatase [AP] in livers of mice experimentally infected with the Egyptian strain of S. mansoni before and after oltipraz treatment was carried out. The drug was given in a single oral dose of 500 mg/kg body weight. The results revealed that the drug led to gradual reduction in the AP mean level after 20 and 30 days from treatment. This was then followed by rise in the enzyme mean level, after 60 days. The drug also caused significant reduction in the AP mean level in livers of the drug control group of mice after 5 and 20 days from oltipraz administration in comparison to normal uninfected controls. These findings might be attributed to a hepatocyto-toxic effect of the drug